Cargando…
Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data
OBJECTIVES: To examine the associations between self-stigma and diabetes duration in a sample of Japanese people with type 2 diabetes. DESIGN: A secondary analysis of a cross-sectional study. SETTING: Two university hospitals, one general hospital and one clinic in Tokyo, Japan. PARTICIPANTS: Outpat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718458/ https://www.ncbi.nlm.nih.gov/pubmed/35380981 http://dx.doi.org/10.1136/bmjopen-2021-055013 |
_version_ | 1784624730966327296 |
---|---|
author | Kato, Asuka Fujimaki, Yuko Fujimori, Shin Isogawa, Akihiro Onishi, Yukiko Suzuki, Ryo Ueki, Kohjiro Yamauchi, Toshimasa Kadowaki, Takashi Hashimoto, Hideki |
author_facet | Kato, Asuka Fujimaki, Yuko Fujimori, Shin Isogawa, Akihiro Onishi, Yukiko Suzuki, Ryo Ueki, Kohjiro Yamauchi, Toshimasa Kadowaki, Takashi Hashimoto, Hideki |
author_sort | Kato, Asuka |
collection | PubMed |
description | OBJECTIVES: To examine the associations between self-stigma and diabetes duration in a sample of Japanese people with type 2 diabetes. DESIGN: A secondary analysis of a cross-sectional study. SETTING: Two university hospitals, one general hospital and one clinic in Tokyo, Japan. PARTICIPANTS: Outpatients with type 2 diabetes aged 20–74 years and receiving treatment from diabetes specialist physicians (n=209) completed a self-administered questionnaire. PRIMARY AND SECONDARY OUTCOME MEASURES: Self-stigma was measured as the primary outcome. Patient Activation Measure, body mass index and haemoglobin A1c were measured as secondary outcomes. RESULTS: One-way analysis of covariance showed significant differences in self-stigma levels between the five groups of diabetes duration (≤5 years, 6–10 years, 11–15 years, 16–21 years and 22 years or more) after controlling for age, gender, education, marital status, diabetes treatment (insulin use) and diabetes-related complications, F(4,198)=2.83, p=0.026. Multiple comparisons using Bonferroni correction showed statistically significant differences in self-stigma levels between the groups with ≤5 years (95% CI 59.63 to 69.73) and 11–15 years with diabetes (95% CI 71.12 to 80.82; p=0.020). The highest mean level of self-stigma was observed in the group having diabetes for 11–15 years. CONCLUSIONS: Self-stigma was associated with diabetes duration and was lowest after diagnosis and gradually increased, with its highest levels being observed in those having diabetes for 11–15 years. Self-stigma takes time to develop and gradually increases in individuals as it is learnt through direct experiences of diabetes-related stigma after self-administering treatment in everyday social situations. |
format | Online Article Text |
id | pubmed-8718458 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-87184582022-01-12 Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data Kato, Asuka Fujimaki, Yuko Fujimori, Shin Isogawa, Akihiro Onishi, Yukiko Suzuki, Ryo Ueki, Kohjiro Yamauchi, Toshimasa Kadowaki, Takashi Hashimoto, Hideki BMJ Open Diabetes and Endocrinology OBJECTIVES: To examine the associations between self-stigma and diabetes duration in a sample of Japanese people with type 2 diabetes. DESIGN: A secondary analysis of a cross-sectional study. SETTING: Two university hospitals, one general hospital and one clinic in Tokyo, Japan. PARTICIPANTS: Outpatients with type 2 diabetes aged 20–74 years and receiving treatment from diabetes specialist physicians (n=209) completed a self-administered questionnaire. PRIMARY AND SECONDARY OUTCOME MEASURES: Self-stigma was measured as the primary outcome. Patient Activation Measure, body mass index and haemoglobin A1c were measured as secondary outcomes. RESULTS: One-way analysis of covariance showed significant differences in self-stigma levels between the five groups of diabetes duration (≤5 years, 6–10 years, 11–15 years, 16–21 years and 22 years or more) after controlling for age, gender, education, marital status, diabetes treatment (insulin use) and diabetes-related complications, F(4,198)=2.83, p=0.026. Multiple comparisons using Bonferroni correction showed statistically significant differences in self-stigma levels between the groups with ≤5 years (95% CI 59.63 to 69.73) and 11–15 years with diabetes (95% CI 71.12 to 80.82; p=0.020). The highest mean level of self-stigma was observed in the group having diabetes for 11–15 years. CONCLUSIONS: Self-stigma was associated with diabetes duration and was lowest after diagnosis and gradually increased, with its highest levels being observed in those having diabetes for 11–15 years. Self-stigma takes time to develop and gradually increases in individuals as it is learnt through direct experiences of diabetes-related stigma after self-administering treatment in everyday social situations. BMJ Publishing Group 2021-12-30 /pmc/articles/PMC8718458/ /pubmed/35380981 http://dx.doi.org/10.1136/bmjopen-2021-055013 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Diabetes and Endocrinology Kato, Asuka Fujimaki, Yuko Fujimori, Shin Isogawa, Akihiro Onishi, Yukiko Suzuki, Ryo Ueki, Kohjiro Yamauchi, Toshimasa Kadowaki, Takashi Hashimoto, Hideki Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data |
title | Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data |
title_full | Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data |
title_fullStr | Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data |
title_full_unstemmed | Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data |
title_short | Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data |
title_sort | associations between diabetes duration and self-stigma development in japanese people with type 2 diabetes: a secondary analysis of cross-sectional data |
topic | Diabetes and Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718458/ https://www.ncbi.nlm.nih.gov/pubmed/35380981 http://dx.doi.org/10.1136/bmjopen-2021-055013 |
work_keys_str_mv | AT katoasuka associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata AT fujimakiyuko associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata AT fujimorishin associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata AT isogawaakihiro associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata AT onishiyukiko associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata AT suzukiryo associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata AT uekikohjiro associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata AT yamauchitoshimasa associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata AT kadowakitakashi associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata AT hashimotohideki associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata |